GenTegra
GenTegra LLC is a privately held life sciences company that sells proprietary chemical reagents for stabilizing DNA and RNA samples at room temperature, serving life science researchers, forensic laboratories, biobanks, and clinical diagnostics customers through direct sales and a global distributor network.
- Company typePrivate
- Founded2013
- HeadquartersPleasanton, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What GenTegra does
GenTegra LLC is a privately held life sciences company founded in 2013 and headquartered in Pleasanton, California, that develops and commercializes chemical reagents for stabilizing DNA and RNA samples at ambient temperature. Its proprietary Active Chemical Protection (ACP) chemistry is the foundation for an integrated product portfolio covering the full sample lifecycle: RNAdvantage protects RNA in fresh tissue, RNAssure protects RNA immediately after purification, GenTegraRNA enables room-temperature shipping for RNAseq, GenTegraDNA supports both research and validated forensic storage, GenSolve handles DNA extraction, GenTegra Collection Cards enable field sampling, and the 2024-launched GenTegra-NEO extends the platform to patient-directed whole blood collection in partnership with NeoterixST.
The company sells primarily to life science researchers, forensic laboratories, biobanking operations, and clinical diagnostics groups, with named use cases spanning RNAseq shipping, gene expression analysis, forensic DNA storage, and remote patient sampling. Go-to-market is a hybrid of direct sales (quote-based, via the company website and [email protected]) and a global distributor network of 15+ partners covering Europe, Asia, and Latin America, supplemented by content marketing across the company website, LinkedIn, X, and YouTube. Revenue is generated through one-time product sales of reagent kits; pricing is not publicly disclosed and is handled by quote.
GenTegra operates as a small specialty reagent business (11-50 employees, single LLC entity, no disclosed institutional funding or parent company), with documented value claims including a roughly 90% reduction in shipping cost (from ~$220 overnight with dry ice to ~$20 ground shipping) and RNA stability of 7+ days at room temperature with RIN values of 7 or higher. The company is positioned around the elimination of cold-chain logistics for genomic samples, with forensic validation providing a regulatory anchor in one of its target verticals.
GenTegra firmographics
Firmographics- Name
- GenTegra
- Legal name
- GenTegra LLC.
- Website
- https://gentegra.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- GenTegra LLC is a privately held life sciences company that sells proprietary chemical reagents for stabilizing DNA and RNA samples at room temperature, serving life science researchers, forensic laboratories, biobanks, and clinical diagnostics customers through direct sales and a global distributor network.
- Ownership category
- akta.pro rank
Where GenTegra is headquartered
LocationHeadquarters
- HQ city
- Pleasanton
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
GenTegra business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- DNA and RNA Stabilization Products: Sale of chemical reagents and kits for stabilizing biological samples. Products include GenTegra DNA, GenTegra RNA, RNAdvantage, RNAssure, and collection cards. Revenue generated through direct product sales to laboratories and research institutions.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
GenTegra product offering
Product offeringCore offering
GenTegra develops and sells chemical reagent kits under its proprietary Active Chemical Protection (ACP) chemistry platform that stabilizes DNA and RNA samples at ambient/room temperature, eliminating the need for cold chain storage and dry ice shipping. The product suite covers tissue collection, post-purification protection, ambient shipping/storage, forensic DNA storage, and sample collection cards for life science, forensic, biobanking, and clinical diagnostics customers.
Product overview
GenTegra offers a suite of chemical protection products for DNA and RNA sample stability, centered on its proprietary Active Chemical Protection™ (ACP) technology. The product portfolio provides protection across the entire sample lifecycle: RNAdvantage for tissue collection, RNAssure for post-purification protection, GenTegraRNA for ambient shipping and storage, GenTegraDNA for DNA protection, GenTegra-NEO for patient-directed whole blood collection, plus GenSolve extraction products and collection cards. Together, these products enable freezer-free, dry ice-free sample handling—eliminating cold chain requirements for genomics samples.
Differentiator
Problem solved
Functional benefit
Brands
- GenTegra RNAdvantage™: Product for better protection of RNA in fresh tissue samples, consistently yields RIN values ≥7
- GenTegra RNAssure™
- GenTegra RNA™
- GenTegraDNA
- GenSolve Classic DNA Extraction
- GenTegra Collection Cards
Products and services
- GenTegra RNAdvantage™ RNA protection reagent specifically designed for fresh tissue sample collection, providing better protection for RNA in fresh tissue samples with consistently high RIN values (≥7). Used by life science researchers and labs performing RNA-based studies.
- GenTegra RNAssure™ RNA protection reagent applied directly after RNA purification that inactivates all residual RNase activity carried over from the purification process. Compatible with standard RNA purification kits without requiring protocol changes.
- GenTegraRNA™ Ambient temperature RNA shipping and storage solution that eliminates the need for dry ice. Stabilized RNA samples withstand elevated temperatures up to 70°C, enabling standard ground shipping. Compatible with RNA-seq, microarray, and qPCR analysis.
- GenTegraDNA DNA protection reagent for life science and forensic lab applications, providing freezer-free DNA storage and validated technology for storing forensic DNA samples at room temperature for decades.
- GenTegra-NEO New RNA stabilization capability for patient-directed whole blood collection, providing room-temperature RNA stability that enables remote sampling and transport without cold chain requirements.
- GenSolve Classic DNA Extraction DNA extraction reagent designed to work in conjunction with GenTegra DNA storage products for complete forensic DNA workflow.
- GenTegra Collection Cards Sample collection cards enabling easy collection, drying, and shipping of DNA/RNA samples for field sample collection and biobanking applications.
Quantifiable outcome
- Shipping cost reduction from ~$220 (overnight with dry ice) to ~$20 (ground shipping)
- +3 more outcomes
Companies that use GenTegra
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
GenTegra technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
GenTegra partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered minor.
- Custom ScienceminorInternational distributor for GenTegra products, providing local sales and support services.
- NBS ScientificminorInternational distributor for GenTegra products in their operating region.
- D-MarkminorDistributor partner for GenTegra life science products.
- BiolinkkminorRegional distribution partner for GenTegra products.
- SR BiosystemsminorDistribution partner for GenTegra life science products.
- Dunn LabminorEuropean distributor for GenTegra products.
- E-BiogenminorDistribution partner for GenTegra products.
- Genome PrecisionminorRegional distributor for GenTegra products.
- InterlabminorInternational distribution partner serving the life science market.
- LobovminorRegional distributor for GenTegra products.
- MotekminorDistribution partner for GenTegra products.
- MPCminorDistributor partner for GenTegra products.
- SyntezzaminorDistribution partner for GenTegra products.
- VishuminorRegional distributor for GenTegra products in their territory.
- Government Scientific SourceminorDistributor specializing in government and institutional sales for GenTegra products.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
GenTegra competitors and assessment
Company assessmentDirect peers
- Streck: Streck develops stabilization products for blood and biological samples, including cell preservation and molecular diagnostics. Their stabilization chemistry for clinical and research sample handling overlaps significantly with GenTegra's nucleic acid stabilization portfolio.
- Norgen Biotek: Norgen Biotek manufactures nucleic acid purification and preservation kits, including sample collection devices and stabilization reagents. Their product line directly overlaps GenTegra's RNA/DNA stabilization kits for research and clinical applications.
- Isohelix (Cell Projects): Isohelix specializes in DNA collection swabs and stabilization kits for buccal and other sample types. They compete in the same DNA sample collection and stabilization niche as GenTegra's Collection Cards and DNA preservation products.
- Zymo Research: Zymo Research offers nucleic acid stabilization reagents, collection devices, and extraction kits serving similar life science and clinical research customers. Their DNA/RNA Shield product competes directly in the ambient-temperature sample preservation category that GenTegra addresses.
- Biomatrica (Thermo Fisher Scientific): Biomatrica was the historical direct competitor in ambient-temperature nucleic acid stabilization before being acquired by Thermo Fisher. Its product line (DNAstable, RNAstable) addresses the same core pain points as GenTegra's ACP chemistry — eliminating cold-chain requirements for DNA/RNA storage and shipping.
- DNA Genotek (OraSure Technologies): DNA Genotek specializes in DNA collection and stabilization devices (e.g., Oragene products) for ambient-temperature sample transport. They serve overlapping use cases including biobanking, forensics, and clinical research with similar value propositions around cold-chain elimination.
Broad incumbents
- Merck (Sigma-Aldrich): Merck's life science division (including legacy Sigma-Aldrich) offers a broad portfolio of molecular biology reagents, including nucleic acid stabilization chemistries that compete with GenTegra's specialized products at large-scale research accounts.
- Qiagen: Qiagen is a major life sciences tools company with nucleic acid purification, stabilization, and sample preparation products across research, forensics, and molecular diagnostics. Their broad portfolio includes ambient-temperature stabilization solutions that overlap with GenTegra's niche.
- Thermo Fisher Scientific: Thermo Fisher is the largest life sciences tools company and acquired Biomatrica, a direct competitor to GenTegra. They serve the same research, forensic, and clinical customers with broader reagent catalogs that include sample stabilization offerings.
Regional players
- COPAN Diagnostics: COPAN specializes in specimen collection and transport systems for microbiology and molecular diagnostics, with strong presence in clinical sample transport. Their collection and transport devices overlap with GenTegra's clinical diagnostics use case for ambient-temperature sample stability.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
GenTegra social profiles
Digital presenceGenTegra financial estimates
Financial estimateRevenue estimate
Valuation estimate
GenTegra leadership team
Management profileNumber of profiles
GenTegra funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GenTegra M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GenTegra
What does GenTegra do?
GenTegra develops and sells chemical reagent kits under its proprietary Active Chemical Protection (ACP) chemistry platform that stabilizes DNA and RNA samples at ambient/room temperature, eliminating the need for cold chain storage and dry ice shipping. The product suite covers tissue collection, post-purification protection, ambient shipping/storage, forensic DNA storage, and sample collection cards for life science, forensic, biobanking, and clinical diagnostics customers.
Is GenTegra a public or private company?
GenTegra is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was GenTegra founded?
GenTegra was founded in 2013. It employs 11 to 50 people.
Where is GenTegra based?
GenTegra is headquartered in Pleasanton, United States, in the North America region.
How does GenTegra make money?
One revenue line is on record: DNA and RNA Stabilization Products.
Who are GenTegra's main competitors?
Direct peers on record are Streck, Norgen Biotek, Isohelix (Cell Projects), Zymo Research, Biomatrica (Thermo Fisher Scientific) and DNA Genotek (OraSure Technologies). Broad incumbents are Merck (Sigma-Aldrich), Qiagen and Thermo Fisher Scientific. COPAN Diagnostics is listed as a regional player.
Does GenTegra have an API?
No public API is recorded for GenTegra.